What Is Genome Research? Core Methods, Multi-Omic Workflows, and How Institutes Deliver It

Genome research is the study of an organism's complete DNA sequence—how it is structured, how it varies, and what it does—and it is carried out at scale through a sequence of technologies rather than a single method. At a large institute, that work typically runs from short-read and long-read sequencing through single-cell and spatial assays, then into functional follow-up such as CRISPR screening and mass spectrometry. This article explains what genome research covers, how it differs from adjacent fields, and how institutes like the McDonnell Genome Institute (MGI) organize these capabilities so you can decide what a project needs.

Genome research vs. genomics, proteomics, and multi-omics

These terms overlap but are not interchangeable:

• Genome research is the broad pursuit of understanding genomes—sequencing them, mapping variation, and determining what specific sequences do. It includes both technology development and biological interpretation.
• Genomics is the discipline and toolset focused on the genome itself: sequencing, assembly, variant calling, and comparative analysis.
• Proteomics studies proteins—their abundance, modifications, and interactions—which often requires different instrumentation, such as mass spectrometry.
• Multi-omics combines data layers (genome, transcriptome, proteome, metabolome, and others) to connect genotype to function.

A practical way to think about it: genome research is the program; genomics, proteomics, and multi-omics are the methods it draws on. MGI describes itself as offering "a full suite of multi-omic services," which reflects this layered structure.

Core methods in genome research

Sequencing: short-read and long-read

Short-read sequencing remains the workhorse for high-accuracy variant detection and large cohort studies. Long-read sequencing resolves regions that short reads handle poorly—structural variants, repetitive regions, and complex rearrangements. MGI lists both under its Genome Technology Access Center, alongside high-throughput proteomics, single-cell genomics, spatial transcriptomics, and computational biology/bioinformatics.

Single-cell and spatial approaches

Single-cell genomics separates signal by individual cell, which matters when a tissue sample contains mixed cell types. Spatial transcriptomics adds location, letting you see where gene expression occurs within a tissue section. Together they move genome research from "what variants exist" toward "which cells are affected and where."

Genome engineering and functional follow-up

Sequence alone rarely answers whether a variant matters. Genome engineering closes that gap. MGI's Genome Engineering & Stem Cell Center covers genome-edited stem cell and cancer cell lines, genome-edited model organisms, patient-derived iPSCs, stem cell differentiation, and CRISPR screening. This is the step where a statistical association becomes a testable causal claim.

Mass spectrometry and functional imaging

MGI's Mass Spectrometry Technology Access Center lists proteomics, metabolomics, lipidomics, deep-scale PTM (post-translational modification) analysis, native mass spectrometry, and spatial multi-omics MS technologies. A separate Functional Imaging group handles massively parallel genetic cellular screening, drug screening, isolating live cells from specific phenotypes, spatial transcriptomics, and image analysis. These capabilities connect genome-level findings to protein-level and cellular-level evidence.

How institutes organize genome research at scale

Large genome research centers are usually structured as shared technology hubs rather than single labs, because no one project needs every instrument. MGI's model illustrates the pattern:

MGI states it has been involved in genomics research since its central role in the Human Genome Project and reports 16 years of average employee tenure, a 95% repeat partner rate, 65 current academic institute partners, and 56 current biopharma partners. Those figures describe the institute's own collaboration history; they are useful context for judging operational stability, not a guarantee of outcomes for any specific project.

What to consider when choosing a genome research partner

• Match the method to the question. Variant discovery, structural variation, cell-type-specific expression, and causal validation each point to different assays. Confirm the partner offers the specific technique your question requires.
• Check whether functional follow-up is in-house. If your project needs to move from association to mechanism, having genome engineering and screening available in the same place reduces handoffs between vendors.
• Ask about computational support. Sequencing volume is only useful with bioinformatics capacity to process it; MGI lists computational biology/bioinformatics as part of its Genome Technology Access Center.
• Look at the collaboration record. Repeat partner rates and partner counts indicate whether an institute routinely handles external projects, as opposed to only internal research.
• Plan for sample constraints. MGI notes that research-grade data standards are especially critical with scarce or degraded patient material—worth raising early if your samples are limited.

Getting started

MGI's site provides a "Start a Project" entry point and "Learn More" links for each technology hub. Before contacting any genome research provider, define three things: the biological question, the sample type and quantity, and whether you need data generation only or data plus functional validation. Those three answers determine which hub—and which combination of methods—your project actually needs.